Barclays PLC Ac Immune Sa Transaction History

Barclays PLC

$436 Billion
Q2 2025

A detailed history of Barclays PLC transactions in Ac Immune Sa stock. As of the latest transaction made, Barclays PLC holds 7,907 shares of ACIU stock, worth $23,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,907

Previous 7,907 -0.0%

Holding current value

$23,088

Previous $16,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.48 - $2.2 $737 - $1,095	498 Added 6.72%	7,907 $16,000
Q1 2025 May 15, 2025	BUY	$1.87 - $2.98 $2,874 - $4,580	1,537 Added 26.18%	7,409 $14,000
Q4 2024 Feb 13, 2025	BUY	$2.67 - $3.75 $14,369 - $20,182	5,382 Added 1098.37%	5,872 $16,000
Q3 2024 Nov 15, 2024	BUY	$2.99 - $4.2 $1,465 - $2,058	490 New	490 $2,000
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $34,138 - $53,434	-7,068 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$6.2 - $8.34 $43,090 - $57,963	6,950 Added 5889.83%	7,068 $48,000
Q2 2021 Aug 13, 2021	SELL	$6.04 - $8.37 $1,654 - $2,293	-274 Reduced 69.9%	118 $1,000
Q1 2021 May 13, 2021	BUY	$5.32 - $8.96 $1,521 - $2,562	286 Added 269.81%	392 $3,000
Q2 2020 Aug 12, 2020	BUY	$6.57 - $8.3 $696 - $879	106 New	106 $1,000
Q1 2020 May 13, 2020	SELL	$4.24 - $9.89 $568 - $1,325	-134 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$4.56 - $8.78 $1,595 - $3,073	-350 Reduced 72.31%	134 $1,000
Q2 2019 Aug 14, 2019	BUY	$4.72 - $5.88 $2,284 - $2,845	484 New	484 $3,000
Q1 2019 May 15, 2019	SELL	$3.65 - $11.68 $23,279 - $74,495	-6,378 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.35 - $11.7 $41,204 - $65,590	5,606 Added 726.17%	6,378 $61,000
Q3 2018 Nov 14, 2018	BUY	$7.88 - $16.45 $6,083 - $12,699	772 New	772 $6,000
Q2 2018 Aug 14, 2018	SELL	$8.17 - $10.9 $44,935 - $59,950	-5,500 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$10.34 - $13.78 $48,598 - $64,766	-4,700 Reduced 46.08%	5,500 $57,000
Q4 2017 Feb 14, 2018	BUY	$10.37 - $12.85 $105,773 - $131,070	10,200	10,200 $131,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

26.9M

Call Options Held

Put Options Held

28.5K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $244M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account